Medicines optimisation - Fylde Coast Clinical Commissioning Groups

Medicines play an important part in promoting wellbeing, preventing ill health and managing disease. More than 700million prescription items are dispensed in England each year with a cost approaching £8billion.

Medicines management can be defined in several ways:

The clinical, cost-effective, safe and secure handling of medicines.
A system of processes and behaviours that determines how medicines are used by the NHS and patients.
Enabling people to make the best possible use of medicines.

Our goal is to achieve the best health outcomes for patients where medicines are involved.

Many decisions relating to medicines management on the Fylde Coast are made on a Lancashire and South Cumbria-wide basis by the Lancashire and South Cumbria Medicines Management Group (LSCMMG).

Further information on medicine guidelines, prescribing guidance, position statements and supporting documents, shared care guidelines and high-cost medicines can be found on the LSCMMG website.

CLICK HERE FOR LSCMMG

Click each header to expand its content

Fylde Coast medicines RAG list

Fylde Coast CCGs RAG List V1 15 December 2021 (xlsx | 74 KB)

Blood and nutrition

Gluten-free

Name	Size	Hits
Gluten Free Foodstuffs	0.2 MB	320
Gluten-Free-Food-Products	0.3 MB	295

Sip feed

Name	Size	Hits
Clinical Need Thickeners Position Statement	0.3 MB	665
Oral Nutritional Supplements (ONS) in care and nursing homes	0.2 MB	427
Position Statement Sip Feeds	0.4 MB	334
SIP Feeds	0.1 MB	379

DVT/VTE/PE

Name	Size	Hits
Dalteparin SCG 2018	0.2 MB	411
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use	0.1 MB	264

Vitamin D

Name	Size	Hits
Flowchart-for-Vitamin-D-Deficiency-in-Primary-Care	0.3 MB	883

Vitamins and minerals

Name	Size	Hits
Policy Unlicensed Herbal Vits Mins Supplements 2013	77 KB	217

Cardiovascular system

Name	Size	Hits

Ear, nose and oropharynx

Name	Size	Hits

Endocrine system

Blood glucose meters and strips (under review)

Name	Size	Hits
Blood glucose meters and test strips Type 2 Diabetes V2.3	0.5 MB	1533

Diabetes

Name	Size	Hits
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus	0.3 MB	310

Thyroid

Name	Size	Hits
Liothyronine position statement	0.2 MB	287

Eye

Name	Size	Hits

Gastro-intestinal system

Genito-urinary system

Name	Size	Hits
Prophylactic supply of catheters post pelvic organ prolapse	0.2 MB	282

Gender dysphoria

Name	Size	Hits
20160422-SSC1620_Primary-Care-Responsibilities-in-Prescribing-and-Monitoring-Hormone-Therapy	0.3 MB	42
Good-practice-guidelines-for-Gender-Dysphoria	0.6 MB	27
Interim Gender Dysphoria Protocol and Service Guidelines 2013-14	0.6 MB	38

Stoma care product

Name	Size	Hits

Infection

Name	Size	Hits
Antimicrobial Formulary April 2021	3.5 MB	141
Antimicrobial Summary Additional information April 2021	25 KB	61

Musculoskeletal system

Arthritis

Name	Size	Hits
Botulinum Toxin A for Spasticity and Contracture of the joint	0.3 MB	294
Second Line Anti-TNF For PsA	0.2 MB	251

DMARDs

Name	Size	Hits
Denosumab for GIO	0.2 MB	275

Shared care drugs included in GP Enhanced contract scheme

Name	Size	Hits

Shared care drugs not included in GP Enhanced contract scheme

Name	Size	Hits

Other MSK

Name	Size	Hits

Nervous system (pain management and psychotics)

Antipsychotic

Name	Size	Hits
Guidance for Prescribing Second Generation Long Acting Antipsychotic Injections	0.6 MB	214
Guidance to support the implementation of the valproate PREVENT programme	0.5 MB	450

Dementia

Name	Size	Hits
Management-of-Behavioural-and-Psychological-Symptoms-of-Dementia-Primary-Care-Summary-Document	0.2 MB	314

Pain

Name	Size	Hits
Cannabis-based-medication-desk-guide-Nov-2018 December-Edit	0.6 MB	275
Clinical Need Soluble Analgesics	0.5 MB	1461

Chronic pain

Name	Size	Hits

Non-chronic pain

Name	Size	Hits

Respiratory system

Name	Size	Hits

Asthma

Name	Size	Hits

COPD

Name	Size	Hits

Inhaler techniques

Name	Size	Hits
How-to-use-your-Accuhaler-inhaler-A4	37 KB	282
How-to-use-your-Aerolizer-inhaler-A4	36 KB	229
How-to-use-your-Autohaler-inhaler-A4	32 KB	239
How-to-use-your-Breezhaler-inhaler-A4	40 KB	256
How-to-use-your-Clickhaler-inhaler-A4	32 KB	272
How-to-use-your-Easi-breathe-inhaler-A4	33 KB	208
How-to-use-your-Easyhaler-inhaler-A4	37 KB	368
How-to-use-your-Ellipta-inhaler-A4	31 KB	285
How-to-use-your-Forspiro-inhaler-A4	48 KB	206
How-to-use-your-Genuair-inhaler-A4	41 KB	363
How-to-use-your-metered-dose-inhaler-A4	51 KB	209
How-to-use-your-metered-dose-inhaler-with-large-volume-spacer-device-A4- ..	37 KB	244
How-to-use-your-metered-dose-inhaler-with-small-volume-spacer-device-A4- ..	35 KB	247
How-to-use-your-NEXThaler-inhaler-A4	88 KB	227
How-to-use-your-Novolizer-inhaler-A4	42 KB	229
How-to-use-your-Respimat-inhaler-A4-leaflet	44 KB	229
How-to-use-your-Spiriva-HandiHaler-inhaler-A4	32 KB	203
How-to-use-your-Spiromax-inhaler-A4	44 KB	246
How-to-use-your-Turbohaler-inhaler-A4	34 KB	336

E-cigarettes

Name	Size	Hits
Health-Professionals-e-cigarettes-briefing-blackpool-council-final	0.2 MB	27

Skin

Name	Size	Hits
Emollients and Sunscreens	0.2 MB	683
Wound Care Formulary	8.2 MB	1738

Miscellaneous

Name	Size	Hits
Free of Charge (FOC) Medicines schemes	0.3 MB	313
NWC-SCN01-Clinical-Practice-Summary-Palliative-Care-Final-version	0.6 MB	344

Prescribing process

Name	Size	Hits
28 Day Prescribing	0.3 MB	762
Changes to repeat prescribing in Blackpool – Frequently Asked Questions	0.4 MB	173
Clinical Need Low Priority Medicines - General	0.3 MB	573
Conditions for which over the counter items should not routinely be prescribed in primary care	0.9 MB	628
Electronic-Repeat-Dispensing-guideline	1.7 MB	2372
Generic Prescribing Guidelines	0.3 MB	486
Guidance-for-7-day-prescriptions-FWCCG-Apr2018	0.5 MB	684
Holiday Medication	0.2 MB	590
MDS Briefing Doc Oct 13	43 KB	263

Other policies

Name	Size	Hits

Rebate policies

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third-party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Fylde & Wyre Current Primary Care Rebate Schemes in place:

Clenil Modulite (Beclometasone) – commenced July 2019
Dabigatran (Pradaxa) – commenced November 2020
Degarelix (Firmagon) – commenced September 2016
Fostair NEXThaler – commenced May 2021
Fostair pMDI – commenced July 2021
Fencino (Fentanyl) – commenced April 2016
Longtec – commenced July 2019
Prostap (Leuprorelin) – commenced April 2020
Rivaroxaban (Xarelto) – commenced October 2019
Sereflo – commenced July 2019
Toujeo (Insulin Glargine) – commenced July 2021
Zacco (Clobazam) – commenced March 2021
Zoladex (Goserelin) commenced January 2019

Blackpool Current Primary Care Rebate Schemes in place:

Clenil Modulite (Beclometasone) – commenced July 2019
Dabigatran (Pradaxa) – commenced November 2020
Degarelix (Firmagon) – commenced September 2016
Fostair NEXThaler – commenced May 2021
Fostair pMDI – commenced July 2021
Fencino (Fentanyl) – commenced October 2018
Longtec – commenced July 2019
Prostap (Leuprorelin) – commenced April 2020
Rivaroxaban (Xarelto) – commenced July 2019
Sereflo – commenced July 2019
Toujeo (Insulin Glargine) – commenced July 2021
Zacco (Clobazam) – commenced March 2021
Zoladex (Goserelin) commenced July 2019

Care homes

Vitamin D and care homes guidance – GOV.UK (www.gov.uk)

Proxy access

BLACKPOOL ONLY: Shared care drugs included in GP enhanced contract scheme

Name	Size	Hits
azathioprinemercaptopurine-shared-care-guideline-version-21	0.2 MB	20
Ciclosporin-SCG-Version	0.2 MB	20
Leflunomide-SCG-Version	0.2 MB	13
Methotrexate-SCG-Version	0.2 MB	20
Penicillamine-SCG-Version	0.2 MB	10
Sodium-Aurothiomalate-SCG-Version	0.2 MB	12
Sulfasalazine-SCG-Version	0.2 MB	12

If you can’t find what you are looking for and think it was once listed in these pages, try the LSCMMG or our files archive